Abbonarsi

Infected total hip arthroplasty revision: One- or two-stage procedure? - 27/03/12

Doi : 10.1016/j.otsr.2011.08.018 
S. Klouche a, , P. Leonard a, V. Zeller a, L. Lhotellier a, W. Graff a, P. Leclerc a, P. Mamoudy a, E. Sariali b
a Department of Orthopaedic Surgery, Diaconesses Croix Saint-Simon Hospitals Group, 125, rue d’Avron, 75020 Paris, France 
b Department of Orthopaedics and Traumatology, La Pitié-Salpêtrière Hospital, 47-83, boulevard de l’hôpital, 75651 Paris cedex 13, France 

Corresponding author. 85, boulevard Pasteur, 75015 Paris, France. Tel.: +33 6 28 35 04 78.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Summary

Introduction

Better outcomes have been reported for two-stage total hip arthroplasty (THA) revision for infection. However, one-stage revision arthroplasty remains an attractive alternative option since it requires only one operation. A decision tree has been developed by the authors in order to determine which type of surgical procedure can be performed safely. The goal of this study was to assess this decision tree for THA replacement in the case of a peri-prosthetic infection.

Hypothesis

A one-stage procedure may be as successful as a two-stage procedure provided some criteria are fulfilled.

Methods

A prospective study included 84patients, all diagnosed with infected THA who had prosthesis replacement. A one-stage exchange was performed in 38cases and a two-stage procedure in 46cases. A two-stage procedure was decided in the case of important bone loss or unidentified germ. Postoperatively, patients received intravenous antibiotics (six weeks), then oral antibiotics (six weeks). The main evaluation criterion was the rate of infection eradication at 2years minimal follow-up since surgery. If new infection was suspected, a hip aspiration was performed to determine whether it was non-eradication (same germ) or a new re-infection (other germ), which was not considered as a failure.

Results

The initial infection was cured in 83 out of 84patients (98.8%), 38 (100%) for the one-stage group and 45 (97.8%) for the two-stage group. Three patients were re-infected with different germs in the two-stage group. Eighty out of 84 (95.2%) patients were infection free, all patients (100%) of the one-stage group and 42patients (91.3%) of two-stage group.

Discussion

If some selection criteria were respected, a high success rate in THA replacement for infection may be achieved with a one-stage procedure. It permits to reduce the costs with no loss of chance for the patients. The decision tree was validated.

Level of evidence

Level III; prospective case control study.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Total hip arthroplasty, Infection, Revision


Mappa


© 2012  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 98 - N° 2

P. 144-150 - aprile 2012 Ritorno al numero
Articolo precedente Articolo precedente
  • De-escalation exchange of loosened locked revision stems to a primary stem design: Complications, stem fixation and bone reconstruction in 15 cases
  • B. Miletic, O. May, N. Krantz, J. Girard, G. Pasquier, H. Migaud
| Articolo seguente Articolo seguente
  • Accuracy of the preoperative planning for cementless total hip arthroplasty. A randomised comparison between three-dimensional computerised planning and conventional templating
  • E. Sariali, R. Mauprivez, F. Khiami, H. Pascal-Mousselard, Y. Catonné

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.